» Articles » PMID: 32199621

Tranilast Induces MiR-200c Expression Through Blockade of RelA/p65 Activity in Leiomyoma Smooth Muscle Cells

Overview
Journal Fertil Steril
Date 2020 Mar 23
PMID 32199621
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the mechanism by which tranilast induces miR-200c expression in leiomyoma smooth muscle cells (LSMCs).

Design: Experimental study.

Setting: Academic research laboratory.

Patient(s): Women undergoing hysterectomy for leiomyoma.

Intervention(s): Blockade of RelA/p65.

Main Outcome Measure(s): Effects of tranilast and blockade of RelA/p65 on miR-200c expression.

Result(s): Tranilast, an inflammation inhibitor, dose-dependently induced miR-200c in LSMCs and myometrium smooth muscle cells (MSMCs), with a more profound effect in LSMCs than in MSMCs. The treatment of LSMCs with Bay 117082, an inhibitor of IκB phosphorylation, further enhanced miR-200c induction by tranilast. The knockdown of RelA/p65 by small interfering RNA also induced miR-200c expression in LSMCs. Although tranilast had no effect on total RelA/p65 protein levels in LSMCs, it significantly induced RelA/p65 phosphorylation at S536 while reducing its activity as well as its nuclear translocation. ChIP assay indicated that tranilast reduces the binding ability of RelA/p65 to miR-200c promoter, resulting in miR-200c induction. Tranilast also inhibited interleukin-8 (IL8) expression in LSMCs. The induction of miR-200c by tranilast partially mediates the inhibitory effect of tranilast on the expression of IL8 and cyclin-dependent kinase 2 in LSMCs.

Conclusion(s): Induction of miR-200c by tranilast in LSMCs is mediated through a transcriptional mechanism involving inhibition of the nuclear factor κB signaling pathway. These results highlight the significance of inflammation in the pathogenesis of leiomyoma and the potential utility of antiinflammatory drugs for treatment of leiomyomas.

Citing Articles

In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study.

Chuang T, Ton N, Rysling S, Khorram O Cells. 2024; 13(13.

PMID: 38994944 PMC: 11240737. DOI: 10.3390/cells13131091.


The immune landscape of uterine fibroids as determined by mass cytometry.

Boos D, Chuang T, Abbasi A, Luzzi A, Khorram O F S Sci. 2024; 5(3):272-282.

PMID: 38925276 PMC: 11404535. DOI: 10.1016/j.xfss.2024.06.004.


Unlocking the potential of tranilast: Targeting fibrotic signaling pathways for therapeutic benefit.

Massoud G, Parish M, Hazimeh D, Moukarzel P, Singh B, Cayton Vaught K Int Immunopharmacol. 2024; 137:112423.

PMID: 38861914 PMC: 11245748. DOI: 10.1016/j.intimp.2024.112423.


The effects of systemic diseases, genetic disorders and lifestyle on keloids.

Xia G, Dohi T, Abdelhakim M, Tosa M, Ogawa R Int Wound J. 2024; 21(4):e14865.

PMID: 38584345 PMC: 10999570. DOI: 10.1111/iwj.14865.


Therapeutic effects of in vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study.

Chuang T, Ton N, Rysling S, Quintanilla D, Boos D, Khorram O Fertil Steril. 2023; 121(4):669-678.

PMID: 38072367 PMC: 10978289. DOI: 10.1016/j.fertnstert.2023.12.006.


References
1.
Peng Y, Laser J, Shi G, Mittal K, Melamed J, Lee P . Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol Cancer Res. 2008; 6(4):663-73. DOI: 10.1158/1541-7786.MCR-07-0370. View

2.
Almeida T, Quispe-Ricalde A, Montes de Oca F, Foronda P, Hernandez M . A high-throughput open-array qPCR gene panel to identify housekeeping genes suitable for myometrium and leiomyoma expression analysis. Gynecol Oncol. 2014; 134(1):138-43. DOI: 10.1016/j.ygyno.2014.04.012. View

3.
Islam M, Protic O, Ciavattini A, Giannubilo S, Tranquilli A, Catherino W . Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells. Fertil Steril. 2014; 102(2):597-606. DOI: 10.1016/j.fertnstert.2014.05.013. View

4.
Chen L, Williams S, Mu Y, Nakano H, Duerr J, Buckbinder L . NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol. 2005; 25(18):7966-75. PMC: 1234328. DOI: 10.1128/MCB.25.18.7966-7975.2005. View

5.
Chuang T, Sakurai R, Gong M, Khorram O, Rehan V . Role of miR-29 in mediating offspring lung phenotype in a rodent model of intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol. 2018; 315(5):R1017-R1026. PMC: 6295497. DOI: 10.1152/ajpregu.00155.2018. View